TOKYO -- The U.S. demanded this week that Japan reassess its system of government-set drug prices, complaining about price cuts often forced on new expensive drugs, a sign that Washington is prepared to intercede on behalf of specific American industries.
Commerce Secretary Wilbur Ross apparently made the request in private talks Wednesday with Yasuhisa Shiozaki, Japan's health minister. Drug prices seemingly did not arise during economic talks Tuesday, when Ross met here with Trade Minister Hiroshige Seko and Vice President Mike Pence held a dialogue with Deputy Prime Minister Taro Aso.
